Literature DB >> 8325754

Corneal epithelial cell attachment with endogenous laminin and fibronectin.

M Ohji1, L Mandarino, N SundarRaj, R A Thoft.   

Abstract

PURPOSE: To evaluate the role of endogenously produced laminin and fibronectin as well as the effect of exogenous laminin and fibronectin in the attachment of human corneal epithelial cells in vitro.
METHODS: Primary cultured human corneal epithelial cells labeled with 3H-thymidine were seeded onto plates coated with laminin or fibronectin, or onto uncoated bacteriologic plates. Attachment of cells was measured in the presence or absence of antisera against laminin or fibronectin, by counting radioactivity.
RESULTS: Human corneal epithelial cells attached to plates coated with human laminin or human fibronectin in a dose-dependent manner, with 69% and 50% of cells attached to the wells coated with 40 micrograms/ml of laminin and fibronectin, respectively (P < 0.001). The percentage of attachment to uncoated bacteriologic plates increased from 1.2% at 45 min of incubation to 6.7% at 90 min, 22.2% at 3 hr, and 40.1% at 6 hr of incubation. Cycloheximide, a protein synthesis inhibitor, completely inhibited cell attachment. Rabbit antiserum against human fibronectin reduced cell attachment to the uncoated plates to 67% of the control value (P < 0.01), whereas rabbit antiserum against human laminin decreased the attachment to 52% of the control (P < 0.01). A combination of these two antisera reduced cell attachment to 46% of the control (P < 0.01).
CONCLUSIONS: Endogenous laminin and fibronectin as well as exogenous laminin and fibronectin play significant roles in the attachment of human corneal epithelial cells in culture.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8325754

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  9 in total

1.  Examining porous bio-active glass as a potential osteo-odonto-keratoprosthetic skirt material.

Authors:  Reeta Huhtinen; Susan Sandeman; Susanna Rose; Elsie Fok; Carol Howell; Linda Fröberg; Niko Moritz; Leena Hupa; Andrew Lloyd
Journal:  J Mater Sci Mater Med       Date:  2013-02-06       Impact factor: 3.896

2.  A comparison of different depth ablations in the treatment of painful bullous keratopathy with phototherapeutic keratectomy.

Authors:  R Maini; L Sullivan; G R Snibson; H R Taylor; M S Loughnan
Journal:  Br J Ophthalmol       Date:  2001-08       Impact factor: 4.638

3.  Electric field-directed cell motility involves up-regulated expression and asymmetric redistribution of the epidermal growth factor receptors and is enhanced by fibronectin and laminin.

Authors:  M Zhao; A Dick; J V Forrester; C D McCaig
Journal:  Mol Biol Cell       Date:  1999-04       Impact factor: 4.138

4.  Analysis of retinal pigment epithelium integrin expression and adhesion to aged submacular human Bruch's membrane.

Authors:  Marco A Zarbin
Journal:  Trans Am Ophthalmol Soc       Date:  2003

5.  Intercellular adhesion molecule-1 expression on human corneal epithelial outgrowth from limbal explant in culture.

Authors:  M Iwata; N Fushimi; Y Suzuki; M Suzuki; T Sakimoto; M Sawa
Journal:  Br J Ophthalmol       Date:  2003-02       Impact factor: 4.638

Review 6.  Biologic keratoprosthesis materials.

Authors:  Joseph B Ciolino; Claes H Dohlman
Journal:  Int Ophthalmol Clin       Date:  2009

7.  Inner limiting membrane as membranous support in RPE sheet-transplantation.

Authors:  Julia Beutel; Lena Greulich; Matthias Lüke; Focke Ziemssen; Peter Szurman; Karl-Ulrich Bartz-Schmidt; Salvatore Grisanti
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-03-07       Impact factor: 3.117

Review 8.  Human corneal cell culture models for drug toxicity studies.

Authors:  Seppo Rönkkö; Kati-Sisko Vellonen; Kristiina Järvinen; Elisa Toropainen; Arto Urtti
Journal:  Drug Deliv Transl Res       Date:  2016-12       Impact factor: 4.617

Review 9.  Topical Umbilical Cord Serum for Corneal Epithelial Defects after Diabetic Vitrectomy.

Authors:  Siamak Moradian; Marzieh Ebrahimi; Azade Kanaani; Amir Faramarzi; Sare Safi
Journal:  J Ophthalmic Vis Res       Date:  2020-04-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.